0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interplay between acetylation and ubiquitination of imitation switch chromatin remodeler Isw1 confers multidrug resistance in Cryptococcus neoformans

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cryptococcus neoformans poses a threat to human health, but anticryptococcal therapy is hampered by the emergence of drug resistance, whose underlying mechanisms remain poorly understood. Herein, we discovered that Isw1, an imitation switch chromatin remodeling ATPase, functions as a master modulator of genes responsible for in vivo and in vitro multidrug resistance in C. neoformans. Cells with the disrupted ISW1 gene exhibited profound resistance to multiple antifungal drugs. Mass spectrometry analysis revealed that Isw1 is both acetylated and ubiquitinated, suggesting that an interplay between these two modification events exists to govern Isw1 function. Mutagenesis studies of acetylation and ubiquitination sites revealed that the acetylation status of Isw1 K97 coordinates with its ubiquitination processes at Isw1 K113 and Isw1 K441 through modulating the interaction between Isw1 and Cdc4, an E3 ligase. Additionally, clinical isolates of C. neoformans overexpressing the degradation-resistant ISW1 K97Q allele showed impaired drug-resistant phenotypes. Collectively, our studies revealed a sophisticated acetylation–Isw1–ubiquitination regulation axis that controls multidrug resistance in C. neoformans.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

          In comparative high-throughput sequencing assays, a fundamental task is the analysis of count data, such as read counts per gene in RNA-seq, for evidence of systematic changes across experimental conditions. Small replicate numbers, discreteness, large dynamic range and the presence of outliers require a suitable statistical approach. We present DESeq2, a method for differential analysis of count data, using shrinkage estimation for dispersions and fold changes to improve stability and interpretability of estimates. This enables a more quantitative analysis focused on the strength rather than the mere presence of differential expression. The DESeq2 package is available at http://www.bioconductor.org/packages/release/bioc/html/DESeq2.html. Electronic supplementary material The online version of this article (doi:10.1186/s13059-014-0550-8) contains supplementary material, which is available to authorized users.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hidden killers: human fungal infections.

            Although fungal infections contribute substantially to human morbidity and mortality, the impact of these diseases on human health is not widely appreciated. Moreover, despite the urgent need for efficient diagnostic tests and safe and effective new drugs and vaccines, research into the pathophysiology of human fungal infections lags behind that of diseases caused by other pathogens. In this Review, we highlight the importance of fungi as human pathogens and discuss the challenges we face in combating the devastating invasive infections caused by these microorganisms, in particular in immunocompromised individuals.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

              Cryptococcus is the most common cause of meningitis in adults living with HIV in sub-Saharan Africa. Global burden estimates are crucial to guide prevention strategies and to determine treatment needs, and we aimed to provide an updated estimate of global incidence of HIV-associated cryptococcal disease.
                Bookmark

                Author and article information

                Contributors
                Role: Reviewing Editor
                Role: Senior Editor
                Journal
                eLife
                Elife
                eLife
                eLife
                eLife Sciences Publications, Ltd
                2050-084X
                22 January 2024
                2024
                : 13
                : e85728
                Affiliations
                [1 ] College of Life and Health Sciences, Northeastern University ( https://ror.org/03awzbc87) Shenyang China
                [2 ] Department of Scientific Research, Chinese Academy of Medical Sciences and Peking Union Medical College ( https://ror.org/02drdmm93) Beijing China
                [3 ] NHC Key Laboratory of AIDS Immunology, The First Affiliated Hospital of China Medical University ( https://ror.org/04wjghj95) Shenyang China
                [4 ] College of Pharmaceutical Sciences, Southwest University ( https://ror.org/01kj4z117) Chongqing China
                [5 ] Medical Research Institute, Southwest University ( https://ror.org/01kj4z117) Chongqing China
                [6 ] Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center New Orleans ( https://ror.org/01qv8fp92) New Orleans United States
                Max Planck Institute for Biology Tübingen ( https://ror.org/0243gzr89) Germany
                Max Planck Institute for Biology Tübingen ( https://ror.org/0243gzr89) Germany
                Max Planck Institute for Biology Tübingen ( https://ror.org/0243gzr89) Germany
                Max Planck Institute for Biology Tübingen ( https://ror.org/0243gzr89) Germany
                Author information
                https://orcid.org/0000-0002-9195-2255
                Article
                85728
                10.7554/eLife.85728
                10834027
                38251723
                f75b202c-151e-4151-a35b-1ade10c15f0a
                © 2024, Meng et al

                This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

                History
                : 21 December 2022
                : 21 January 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100012166, National Key Research and Development Program of China;
                Award ID: 2022YFC2303000
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 31870140
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100018617, Liaoning Revitalization Talents Program;
                Award ID: XLYC1807001
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: AI156254
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: AI168867
                Award Recipient :
                The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.
                Categories
                Research Article
                Microbiology and Infectious Disease
                Custom metadata
                Isw1 acts as a master regulator in modulating the expression of drug-resistance genes, and this regulatory mechanism is dependent on the interaction of Isw1 acetylation and ubiquitination.

                Life sciences
                acetylation–ubiquitination crosstalk,antifungal drug resistance,cryptococcus neoformans,other

                Comments

                Comment on this article